GKB Ophthalmics (Small Cap - High Growth) Share Target 2024, 2025 To 2039
|
GKB Ophthalmics Limited |
|||
|
Price: ₹100.01 | ||
| 52 Week Low: ₹74.10 52 Week High: ₹136.40 |
|||
| Market Capital: 50.12 Crore (Smallcap) | |||
| -> | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: GKB Ophthalmics Share Price Target For 2024
- 1.1.1: GKB Ophthalmics Share Price Target Table For 2024
- 1.1.2: Short-Term Technical Outlook
- 1.2: GKB Ophthalmics Share Price Target For 2025
- 1.2.1: GKB Ophthalmics Share Price Target Table For 2025
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: GKB Ophthalmics Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
- 3: GKB Ophthalmics Financial Performance
- 3.0.1: Is GKB Ophthalmics A Good Buy For Long Term?
To predict the GKB Ophthalmics's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
GKB Ophthalmics Share Price Target For 2024
The line chart displays the monthly closing prices of GKB Ophthalmics with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for GKB Ophthalmics shares in 2024, see the table below.
GKB Ophthalmics Share Price Target Table For 2024
| Level | Value | Analysis |
|---|---|---|
| 2024 Target 3 | 104.85 (+4.83%) | Price Action: 31 Oct 2024 High |
| 2024 Target 2 | 103.8 (+3.78%) | Price Action: 21 May 2024 High |
| 2024 Target 1 | 102.75 (+2.73%) | Price Action: 04 Jan 2024 High |
| Current Price | 100.01 | GKB Ophthalmics's share price as of 26 Dec 2024 |
| Stop Loss 1 | 98.75 (-1.26%) | Price Action: Mar 2023 Low |
| Stop Loss 2 | 97.6 (-2.41%) | Price Action: 21 Nov 2023 High |
| Stop Loss 3 | 96.61 (-3.4%) | Price Action: 12 Apr 2024 High |
Short-Term Technical Outlook
Current Technical Position: GKB Ophthalmics is showing mixed momentum signals near key moving averages.
Key Technical Level: The 25-day moving average at ₹99.24 serves as the nearest technical reference point.
Historical Returns: 3-month: -2.76% | 6-month: -1.21% | 1-year: -0.05%
GKB Ophthalmics Share Price Target For 2025
The line chart displays the monthly closing prices of GKB Ophthalmics with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for GKB Ophthalmics shares in 2025, see the table below.
GKB Ophthalmics Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 144.53 (+44.51%) | Price Action: Chart |
| 2025 Target 2 | 141.84 (+41.82%) | Price Action: Chart |
| 2025 Target 1 | 140.44 (+40.42%) | Fibonacci Extension Level 64.90% |
| Current Price | 100.01 | GKB Ophthalmics's share price as of 26 Dec 2024 |
| Stop Loss 1 | 90.77 (-9.24%) | Price Action: 19 Jul 2023 High |
| Stop Loss 2 | 89.65 (-10.36%) | Price Action: Apr 2021 High |
| Stop Loss 3 | 88.75 (-11.26%) | Price Action: 01 Mar 2024 High |
Long-Term Technical Outlook
52-Week Range Analysis: GKB Ophthalmics is currently trading at 41.6% of its 52-week range (₹74.1 - ₹136.4).
Long-Term Trend Analysis: The stock is in a bearish long-term trend, trading below key long-term moving averages.
Long-Term Performance: 1-year: -0.05% | 3-year: +15.22% | 5-year: +70.23%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
GKB Ophthalmics Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹100.01 | ||
| 2024 | ₹118.61 | +18.59% | ₹120.39 |
| 2025 | ₹123.01 | +3.7% | ₹143.69 |
| 2026 | ₹149.37 | +21.42% | ₹170.18 |
| 2027 | ₹196.66 | +31.65% | ₹199.61 |
| 2028 | ₹194.11 | -1.29% | ₹214.95 |
| 2029 | ₹213.02 | +9.74% | ₹223.15 |
| 2030 | ₹207.47 | -2.6% | ₹249.64 |
| 2031 | ₹239.55 | +15.46% | ₹276.12 |
| 2032 | ₹302.61 | +26.32% | ₹307.15 |
| 2033 | ₹288.51 | -4.65% | ₹320.34 |
| 2034 | ₹307.43 | +6.55% | ₹329.09 |
| 2035 | ₹291.94 | -5.03% | ₹355.58 |
| 2036 | ₹329.73 | +12.94% | ₹382.06 |
| 2037 | ₹408.55 | +23.9% | ₹414.68 |
| 2038 | ₹382.91 | -6.27% | ₹425.72 |
| 2039 | ₹391.95 | +2.36% | ₹435.04 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
GKB Ophthalmics Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 50.12 Crore | Market valuation of GKB Ophthalmics's shares. |
| Revenue (TTM) | 88.25 Crore | Total revenue generated by GKB Ophthalmics over the past twelve months. |
| Net Income (TTM) | -2.81 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | -1.58% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | +28.74% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
+20.69% | Change in revenue compared to the previous quarter. |
| Debt-to-Equity (D/E) Ratio |
0.17 | Company's total debt divided by total shareholder equity. |
| Total Debt | 11.48 Crore | Sum of GKB Ophthalmics's current & long-term financial obligations. |
| Total Cash | 3.23 Crore | Total amount of liquid funds available to GKB Ophthalmics. |
Is GKB Ophthalmics A Good Buy For Long Term?
GKB Ophthalmics, a small-cap stock with a market capitalization of ₹50.12 crore, presents a mixed picture for long-term investors. While it boasts substantial revenue (₹88.25 crore TTM), a net loss of ₹2.81 crore and high debt (₹11.48 crore in Q1 2024-25) raise concerns. Although the Q1 cash balance is ₹3.23 crore, negative returns over the past 6 and 12 months (-21.30% and -2.38% respectively) signal caution. Despite a positive 3-year return (19.46%), the 5-year return of -28.39% indicates considerable volatility. Overall, GKB Ophthalmics is not a good buy for long-term investment at this time, given its current financial performance and debt levels.
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
